Showing results (91-100 of 254) with videos related to
Sort By:
Pageof 26
Journal of Medicinal Chemistry|July 14, 2012
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndromeLina Yin, Simon Lucas, Frauke Maurer, et al.Archiv Der Pharmazie|July 9, 2004
Synthesis and evaluation of a dimer of 2-(4-pyridylmethyl)-1-indanone as a novel nonsteroidal aromatase inhibitorRanju Gupta, Dharam Paul Jindal, Birinder Jit, et al.Journal of Medicinal Chemistry|December 4, 2008
In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivativesSimon Lucas, Ralf Heim, Christina Ries, et al.Archiv Der Pharmazie|July 12, 2008
Structural modifications of salicylates: inhibitors of human CD81-receptor HCV-E2 interactionMarcel Holzer, Sigrid Ziegler, Alexander Neugebauer, et al.European Journal of Medicinal Chemistry|November 1, 2011
Triazole ring-opening leads to the discovery of potent nonsteroidal 17β-hydroxysteroid dehydrogenase type 2 inhibitorsKuiying Xu, Yaseen A Al-Soud, Marie Wetzel, et al.European Journal of Medicinal Chemistry|June 16, 2014
Inhibition of 17β-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of new potent inhibitors with thioether linkerAhmed S Abdelsamie, Emmanuel Bey, Nina Hanke, et al.Journal of Chemical Information and Modeling|May 23, 2006
Pharmacophore modeling and in silico screening for new P450 19 (aromatase) inhibitorsDaniela Schuster, Christian Laggner, Theodora M Steindl, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2010
N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2)Christina Zimmer, Marieke Hafner, Michael Zender, et al.Journal of Medicinal Chemistry|October 7, 2011
Introduction of an electron withdrawing group on the hydroxyphenylnaphthol scaffold improves the potency of 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitorsMarie Wetzel, Sandrine Marchais-Oberwinkler, Enrico Perspicace, et al.Journal of Medicinal Chemistry|October 28, 2010
Bicyclic substituted hydroxyphenylmethanones as novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseasesAlexander Oster, Stefan Hinsberger, Ruth Werth, et al.Pageof 26